POTSDAM -- Researchers from Clarkson University have secured funding of $330,000 from the National Science Foundation for their work in nano-biosensing. The NSF Nano-Biosensing program has awarded …
This item is available in full to subscribers.
To continue reading, you will need to either log in to your subscriber account, or purchase a new subscription.
If you are a digital subscriber with an active, online-only subscription then you already have an account here. Just reset your password if you've not yet logged in to your account on this new site.
Otherwise, click here to view your options for subscribing.
Please log in to continue |
POTSDAM -- Researchers from Clarkson University have secured funding of $330,000 from the National Science Foundation for their work in nano-biosensing.
The NSF Nano-Biosensing program has awarded the grant to professors from Clarkson and the University of Missouri, which is rceiving $50,000 from the NSF, for their project, "Collaborative Research: Sense-and-Act Systems for Substance Release Modeling Drug Delivery Triggered by Immune-Sensing Based on Nanostructured Electrodes," Clarkson said.
The team consists of Clarkson’s professor of chemistry and biomolecular science Evgeny Katz and professor of physics Vladimir Privman, and UM associate professor in medical pharmacology Luis A. Martinez-Lemus.
The award is given over three years.
Katz said the money will support students and post-doctoral work on the project. He said the probability of getting a grant such as this is small because many people work in the field of biosensors.